GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acusphere Inc (OTCPK:ACUS) » Definitions » Return-on-Tangible-Equity

Acusphere (Acusphere) Return-on-Tangible-Equity : 0.00% (As of Sep. 2008)


View and export this data going back to 2003. Start your Free Trial

What is Acusphere Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Acusphere's annualized net income for the quarter that ended in Sep. 2008 was $-41.13 Mil. Acusphere's average shareholder tangible equity for the quarter that ended in Sep. 2008 was $-5.58 Mil. Therefore, Acusphere's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2008 was N/A%.

The historical rank and industry rank for Acusphere's Return-on-Tangible-Equity or its related term are showing as below:

ACUS's Return-on-Tangible-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.475
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Acusphere Return-on-Tangible-Equity Historical Data

The historical data trend for Acusphere's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acusphere Return-on-Tangible-Equity Chart

Acusphere Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Return-on-Tangible-Equity
Get a 7-Day Free Trial - -59.99 -86.71 -105.45 -130.75

Acusphere Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -129.10 -167.05 -318.03 -945.59 -

Competitive Comparison of Acusphere's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Acusphere's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acusphere's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acusphere's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Acusphere's Return-on-Tangible-Equity falls into.



Acusphere Return-on-Tangible-Equity Calculation

Acusphere's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2007 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2007 )  (A: Dec. 2006 )(A: Dec. 2007 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2007 )  (A: Dec. 2006 )(A: Dec. 2007 )
=-53.73/( (58.449+23.74 )/ 2 )
=-53.73/41.0945
=-130.75 %

Acusphere's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2008 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2008 )  (Q: Jun. 2008 )(Q: Sep. 2008 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2008 )  (Q: Jun. 2008 )(Q: Sep. 2008 )
=-41.132/( (-0.822+-10.333)/ 2 )
=-41.132/-5.5775
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2008) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Acusphere  (OTCPK:ACUS) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Acusphere Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Acusphere's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Acusphere (Acusphere) Business Description

Traded in Other Exchanges
N/A
Address
99 Hayden Avenue, Suite 385, Lexington, MA, USA, 02421
Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.
Executives
Martyn D Greenacre director 41 MOORES ROAD, FRAZER PA 19355
Garen G Bohlin director C/O PRAECIS PHARMACEUTICALS INC, 830 WINTER STREET, WALTHAM MA 02451
Sandra L Fenwick director C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Frederick W Ahlholm officer: VP Finance C/O MINERVA NEUROSCIENCES, INC., 1601 TRAPELO ROAD, SUITE 286, WALTHAM MA 02451
John F Thero other: Former Senior VP/CFO C/O AMARIN PHARMA, INC., 1430 ROUTE 6, BEDMINSTER NJ 07921
Kate Mitchell director 950 TOWER LANE, STE 700, FOSTER CITY CA 94404
Bank Of America Corp /de/ 10 percent owner BANK OF AMERICA CORPORATE CENTER, 100 N TRYON ST, CHARLOTTE NC 28255
Bank Of America Na 10 percent owner 100 N. TRYON STREET, CHARLOTTE NC 28255
Nb Holdings Corp 10 percent owner 100 NORTH TRYON STREET, CHARLOTTE NC 28255
Terrance Mcguire director C/O POLARIS VENTURE PARTNERS LP, 1000 WINTER STREET, SUITE 3350, WALTHAM MA 02154

Acusphere (Acusphere) Headlines

No Headlines